Difference between revisions of "Cross-Paradigm Behavioral Health Exchange Project"
| Line 1: | Line 1: | ||
| − | =Cross-Paradigm Behavioral Health (BH) Exchange Project= | + | =Cross-Paradigm Behavioral Health (BH) Data Exchange Project= |
*[http://gforge.hl7.org/gf/project/cbcc/frs/?action=FrsReleaseBrowse&frs_package_id=186 HL7 GForge Release] | *[http://gforge.hl7.org/gf/project/cbcc/frs/?action=FrsReleaseBrowse&frs_package_id=186 HL7 GForge Release] | ||
*Submit feedback using the [http://gforge.hl7.org/gf/project/cbcc/tracker/?action=TrackerItemBrowse&tracker_id=1042 Tracker] | *Submit feedback using the [http://gforge.hl7.org/gf/project/cbcc/tracker/?action=TrackerItemBrowse&tracker_id=1042 Tracker] | ||
Revision as of 16:13, 4 August 2016
Contents
Cross-Paradigm Behavioral Health (BH) Data Exchange Project
- HL7 GForge Release
- Submit feedback using the Tracker
Drug Toxicology Scenario
The following is an example scenario intended to illustrate how implementers will use
Drug Toxicology Ordering
A BH EHR sends a Drug Toxicology Order (as an LOI-conformant V2.5.1 message):
- The drug toxicology panel (24349-3^Drugs of abuse 5 panel - Urine) is supported by the laboratory
- The order references the specimen (urine)
MSH|^~\&|BH-EHR^2.16.840.1.113883.3.72.5.22^ISO|EHR Facility^2.16.840.1.113883.3.72.5.23^ISO|Reference Laboratory^2.16.840.1.113883.3.72.5.20^ISO|Lab Facility^2.16.840.1.113883.3.72.5.21^ISO|20160211184101-0500||OML^O21^OML_O21|NIST-LOI_8.0_1.1-GU|T|2.5.1|||AL|NE|||||LOI_Common_Component^LOI Base Profile^2.16.840.1.113883.9.66^ISO~LOI_GU_Component^LOI GU Profile^2.16.840.1.113883.9.78^ISO~LAB_PRU_Component^LOI PRU Profile^2.16.840.1.113883.9.82^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Share^Sally^A^^^^L||19281011|F||2106-3^White^HL70005|1500 Patient Way^Apt 4^Huntington Park^CA^90255^^H|||||||||||H^Hispanic^HL70189
ORC|NW|ORD798642-3^BH-EHR^2.16.840.1.113883.3.72.7.83^ISO||ORD798642^BH-EHR^2.16.840.1.113883.3.72.7.83^ISO|||||20160124||57422^Hippocrates^Harold|57422^Hippocrates^Harold^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^^PH^^^626^9876543^1||||||2^Patient has been informed of responsibility, and agrees to pay for service^HL70339
OBR|1|ORD798642-3^BH-EHR^2.16.840.1.113883.3.72.7.83^ISO||24349-3^Drugs of abuse 5 panel - Urine^LN|||201603190830-0800|||||||||57422^Hippocrates^Harold^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^^PH^^^626^9876543^1
DG1|1||F43.10^Posttraumatic Stress Disorder^I10C|||F|||||||||3
SPM|1|SP798642-2&BH-EHR&2.16.840.1.113883.3.72.7.83&ISO||122575003^UrineSpecimen^SCT|||||||||||||201603190830-0800
Drug Toxicology Results Reporting
The laboratory receives the specimen from the BH provider and performs the tests specified in the panel definition (http://s.details.loinc.org/LOINC/24349-3.html?sections=Simple). The lab transmits the Lab Results message (LRI conformance V2.5.1 message) to the BH EHR to be reviewed and interpreted by the provider.
The example results transactions are using 42860-7^Cannabinoids [Mass/volume] in Urine rather than 52954-5^Cannabinoids [Moles/volume] in Urine to analyze the level of Cannabinoids in urine.
MSH|^~\&|Reference Laboratory^2.16.840.1.113883.3.72.5.20^ISO|Lab Facility^2.16.840.1.113883.3.72.5.21^ISO|BH-EHR^2.16.840.1.113883.3.72.5.22^ISO|EHR Facility^2.16.840.1.113883.3.72.5.23^ISO|20160601140551-0500||ORU^R01^ORU_R01|NIST-LRI-GU-002.00|T|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Component^^2.16.840.1.113883.9.12^ISO~LRI_RU_Component^^2.16.840.1.113883.9.14^ISO
PID|1||PATID1234^^^&2.16.840.1.113883.3.72.5.30.2&ISO^MR||Share^Sally^A^^^^L||19281011|F||2106-3^White^HL70005|1500 Patient Way^Apt 4^Huntington Park^CA^90255^^H|||||||||||H^Hispanic^HL70189
ORC|NW|ORD798642-3^BH-EHR^2.16.840.1.113883.3.72.7.83^ISO||ORD798642^BH-EHR^2.16.840.1.113883.3.72.7.83^ISO|||||20160124||57422^Hippocrates^Harold|57422^Hippocrates^Harold^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI||^^PH^^^626^9876543^1||||||2^Patient has been informed of responsibility, and agrees to pay for service^HL70339
OBR|1|ORD798642-3^BH-EHR^2.16.840.1.113883.3.72.7.83^ISO||24349-3^Drugs of abuse 5 panel - Urine^LN|||201603190830-0800|||||||||57422^Hippocrates^Harold^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI|^^PH^^^626^9876543^1
OBX|1|NM|8150-5^Amphetamines [Mass/volume] in Urine^LN||23|ug/L^micrograms per liter^UCUM|0 to 10|H|||F|||20160103143428-0800|||||20160103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Lister^John^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|2|NM|3394-4^Benzoylecgonine [Mass/volume] in Urine^LN||0.3|mg/L^milligrams per liter^UCUM|0 to 0.1|H|||F|||20160601133428-0800|||||20160103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Lister^John^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|3|NM|42860-7^Cannabinoids [Mass/volume] in Urine^LN||15|ug/L^micrograms per liter^UCUM|0 to 10|H|||F|||20160601133428-0800|||||20160103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Lister^John^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|4|NM|8220-6^Opiates [Mass/volume] in Urine^LN||0|ng/L^nanograms per liter^UCUM|0 to 10|N|||F|||20160601133428-0800|||||20160103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Lister^John^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
OBX|5|NM|3937-0^Phencyclidine [Mass/volume] in Urine^LN||23|ug/L^micrograms per liter^UCUM|0 to 10|H|||F|||20160601133428-0800|||||20160103163428-0800||||Century Hospital^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^XX^^^987|2070 Test Park^^Los Angeles^CA^90067^^B|2343242^Lister^John^^^^^^&2.16.840.1.113883.3.72.5.30.1&ISO^L^^^DN
SPM|1|SP798642-2&BH-EHR&2.16.840.1.113883.3.72.7.83&ISO||122575003^UrineSpecimen^SCT|||||||||||||201603190830-0800
